keyword
https://read.qxmd.com/read/38680294/repurposing-drugs-to-modulate-sortilin-structure-guided-strategies-against-atherogenesis-coronary-artery-disease-and-neurological-disorders
#1
JOURNAL ARTICLE
Mohammad Ali Abdullah Almoyad, Shadma Wahab, Sourav Mohanto, Nida Jamil Khan
Sortilin (SORT1) is a multifunctional protein intricately involved in atherogenesis, coronary artery disease (CAD), and various neurological disorders. It has materialized as a potential pharmacological target for therapeutic development due to its diverse biological roles in pathological processes. Despite its central role under these conditions, effective therapeutic strategies targeting SORT1 remain challenging. In this study, we introduce a drug repurposing strategy guided by structural insights to identify potent SORT1 inhibitors with broad therapeutic potential...
April 23, 2024: ACS Omega
https://read.qxmd.com/read/38668624/first-synthesis-of-ergotamine-13-cd-3-and-ergotaminine-13-cd-3-from-unlabeled-ergotamine
#2
JOURNAL ARTICLE
Sven-Oliver Herter, Hajo Haase, Matthias Koch
Ergot alkaloids (EAs) formed by Claviceps fungi are one of the most common food contaminants worldwide, affecting cereals such as rye, wheat, and barley. To accurately determine the level of contamination and to monitor EAs maximum levels set by the European Union, the six most common EAs (so-called priority EAs) and their corresponding epimers are quantified using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). The quantification of EAs in complex food matrices without appropriate internal standards is challenging but currently carried out in the standard method EN 17425:2021 due to their commercial unavailability...
April 20, 2024: Toxins
https://read.qxmd.com/read/38655598/dihydroergotamine-mesylate-nasal-spray-an-acute-treatment-option-for-migraine-in-adults
#3
REVIEW
Marcello Silvestro, Ilaria Orologio, Alessandro Tessitore, Francesca Trojsi, Gioacchino Tedeschi, Antonio Russo
INTRODUCTION: Although the landscape of migraine symptomatic treatment has been enriched by novel effective drugs, it is mandatory to critically reappraise older molecules to ascertain whether they could still represent reliable alternatives in specific endophenotypes of patients or migraine attacks. Among these, dihydroergotamine (DHE) nasal spray has been shown to be effective and is characterized by greater tolerability and manageability than the parenteral DHE formulation. AREAS COVERED: In this narrative review, the authors describe the pharmacodynamic and pharmacokinetic properties of DHE nasal spray and explore the results of the trials which explored its efficacy, safety and tolerability as migraine symptomatic treatment...
April 24, 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38542933/the-indiscriminate-chemical-makeup-of-secondary-metabolites-derived-from-endophytes-harvested-from-aloe-barbadensis-miller-in-south-africa-s-limpopo-region
#4
JOURNAL ARTICLE
Mpho Mamphoka Nchabeleng, Thierry Youmbi Fonkui, Green Ezekiel
The efficacy of 23 bacterial isolates obtained from surface-sterilized stems and leaves of three medicinal plants ( Aloe barbadensis Miller, Artemisia afra , and Moringa oleifera ) was investigated in an endeavour to prevent the growth of Mycobacterium bovis using the cross-streak method. Endophytes were isolated by incubating sterile plant materials on nutrient agar at 30 °C for 5 days. Two isolates showing activity were subsequently utilized to produce the extracts. Whole-genome sequencing (WGC) was used to identify the isolates...
March 14, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38529713/mechanistic-insights-into-sodium-ion-mediated-ligand-binding-affinity-and-modulation-of-5-ht2b-gpcr-activity-implications-for-drug-discovery-and-development
#5
JOURNAL ARTICLE
Arushi Chauhan, Jitender Singh, Namrata Sangwan, Pramod K Avti
PURPOSE: The G-protein coupled receptor (GPCR) family, implicated in neurological disorders and drug targets, includes the sensitive serotonin receptor subtype, 5-HT2B. The influence of sodium ions on ligand binding at the receptor's allosteric region is being increasingly studied for its impact on receptor structure. METHODS: High-throughput virtual screening of three libraries, specifically the Asinex-GPCR library, which contains 8,532 compounds and FDA-approved (2466 compounds) and investigational compounds (2731)) against the modeled receptor [4IB4-5HT2B RM ] using the standard agonist/antagonist (Ergotamine/Methysergide), as previously selected from our studies based on ADMET profiling, and further on basis of binding free energy a single compound - dihydroergotamine is chosen...
March 26, 2024: Journal of Receptor and Signal Transduction Research
https://read.qxmd.com/read/38370480/effects-of-hallucinogenic-drugs-on-the-human-heart
#6
REVIEW
Joachim Neumann, Stefan Dhein, Uwe Kirchhefer, Britt Hofmann, Ulrich Gergs
Hallucinogenic drugs are used because they have effects on the central nervous system. Their hallucinogenic effects probably occur via stimulation of serotonin receptors, namely, 5-HT2A -serotonin receptors in the brain. However, a close study reveals that they also act on the heart, possibly increasing the force of contraction and beating rate and may lead to arrhythmias. Here, we will review the inotropic and chronotropic actions of bufotenin, psilocin, psilocybin, lysergic acid diethylamide (LSD), ergotamine, ergometrine, N,N-dimethyltryptamine, and 5-methoxy-N,N-dimethyltryptamine in the human heart...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38313995/benefits-and-risks-of-medications-used-in-the-management-of-hypotension-a-review
#7
REVIEW
Thangwaritorn Skylynn, Thomas Abel, Lee Christopher, Ghafary Suliman, Rivera Dominic, Varughese Joel, Zeyu Yu, Sudhakar Pemminati
This comprehensive literature review addresses the scarcity and limited study of hypotension treatments compared to abundant antihypertensive drugs. Hypotension, categorized as absolute, relative, or orthostatic, has diverse causes. This review explores various treatments, including drugs affecting the sympathetic nervous system, such as midodrine, dihydroergotamine, and ergotamine, which have shown efficacy in managing hypotension. Dopamine agonists/antagonists and other drugs such as ephedrine, norepinephrine, and fludrocortisone are also discussed, each with distinct mechanisms and applications...
January 2024: Curēus
https://read.qxmd.com/read/38307647/evidence-based-symptomatic-treatment-of-migraine
#8
REVIEW
Dimos D Mitsikostas, Thomas N Ward
Symptomatic treatment of migraine includes patient education, mainly to avoid medication overuse and known trigger factors, as well as pharmaceutical and nonpharmaceutical interventions. Disease-specific and mechanism-based agents include ergotamine and dihydroergotamine targeting the adrenergic, dopaminergic, and serotoninergic systems followed by triptans, specific agonists for 5-HT1B/1D/1F receptors, the latest being more favorable in terms of safety and documentation of efficacy. Recently, antagonists of calcitonin gene-related peptide (gepants) and selective agonists of the 5-HT1F receptor (ditans) have been added, with promising efficacy and safety...
2024: Handbook of Clinical Neurology
https://read.qxmd.com/read/38307644/the-5-ht-1b-and-5-ht-1d-agonists-in-acute-migraine-therapy-ergotamine-dihydroergotamine-and-the-triptans
#9
REVIEW
Mark Whealy, Werner J Becker
The advent of the triptans revolutionized acute migraine treatment. The older migraine-specific drugs, the ergot alkaloids (ergotamine and dihydroergotamine), also relieve migraine attacks through agonism at the 5-HT1B and 5-HT1D receptors, but the triptans have much greater specificity for these receptors. Unlike the ergot alkaloids, the triptans do not activate many other receptor types, and therefore are much better tolerated. This reduction in side effects greatly enhanced their clinical utility as it allowed a far greater proportion of patients to take a full therapeutic dose...
2024: Handbook of Clinical Neurology
https://read.qxmd.com/read/38264299/risks-for-animal-health-related-to-the-presence-of-ergot-alkaloids-in-feed
#10
JOURNAL ARTICLE
Dieter Schrenk, Margherita Bignami, Laurent Bodin, James Kevin Chipman, Jesús Del Mazo, Bettina Grasl-Kraupp, Christer Hogstrand, Jean-Charles Leblanc, Carlo Stefano Nebbia, Elsa Nielsen, Evangelia Ntzani, Annette Petersen, Salomon Sand, Tanja Schwerdtle, Christiane Vleminckx, Heather Wallace, Jürgen Gropp, Patrick Mulder, Isabelle P Oswald, Ruud Woutersen, Jose Ángel Gómez Ruiz, Elena Rovesti, Laurentius Ron Hoogenboom
The European Commission requested EFSA to provide an update of the 2012 Scientific Opinion of the Panel on Contaminants in the Food Chain (CONTAM) on the risks for animal health related to the presence of ergot alkaloids (EAs) in feed. EAs are produced by several fungi of the Claviceps and Epichloë genera. This Opinion focussed on the 14 EAs produced by C. purpurea (ergocristine, ergotamine, ergocornine, α- and β-ergocryptine, ergometrine, ergosine and their corresponding 'inine' epimers). Effects observed with EAs from C...
January 2024: EFSA journal
https://read.qxmd.com/read/38239555/closing-the-gap-a-case-report-on-a-blood-patch-solution-for-cerebrospinal-fluid-leak
#11
Guilherme Sousa, Bárbara Alves, Filipa Cunha, Juliana Magalhães, Eduarda Figueiredo, Luís Abreu
Spontaneous intracranial hypotension is a condition resulting from cerebrospinal fluid leaks at the spinal level that disrupt the regulation of intracranial pressure. This disorder is an uncommon cause of debilitating headaches but can have variable clinical manifestations, which contributes to delayed diagnosis and potentially severe consequences. The standard treatment consists of conservative measures such as bed rest, hydration, and a pharmacological approach with paracetamol, caffeine, ergotamine, and dexamethasone...
December 2023: Curēus
https://read.qxmd.com/read/38213138/exploring-the-therapeutic-potential-of-alkaloids-in-alzheimer-s-disease-management
#12
JOURNAL ARTICLE
Randhir Dahiya, Nidhi Rani, Rajwinder Kaur, Geeta Chahal, Praveen Kumar, Gagandeep Kaur
BACKGROUND: Alkaloids are important phytoconstituents obtained from various plant sources. The study's primary goal is to assess the anti-Alzheimer potential of alkaloids using a molecular docking study. Alzheimer's disease (AD) is considered a gradual decline in memory, reasoning, decision-making, orientation to one's physical surroundings, and language. METHOD AND MATERIAL: The main target i.e. acetylcholinesterase proteins was selected for the molecular docking study...
January 11, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38176507/identifying-repurposed-drugs-as-potential-inhibitors-of-apolipoprotein-e-a-bioinformatics-approach-to-target-complex-diseases-associated-with-lipid-metabolism-and-neurodegeneration
#13
JOURNAL ARTICLE
Mohammad Furkan, Mohd Shahnawaz Khan, Moyad Shahwan, Nageeb Hassan, Dharmendra Kumar Yadav, Saleha Anwar, Rizwan Hasan Khan, Anas Shamsi
Apolipoprotein E (ApoE), a pivotal contributor to lipid metabolism and neurodegenerative disorders, emerges as an attractive target for therapeutic intervention. Within this study, we deployed an integrated in-silico strategy, harnessing structure-based virtual screening, to identify potential compounds from the expansive DrugBank database. Employing molecular docking, we unveil initial hits by evaluating their binding efficiency with ApoE. This first tier of screening narrows our focus to compounds that exhibit a strong propensity to bind with ApoE...
January 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38158799/interdigitation-of-lipids-for-vesosomal-formulation-of-ergotamine-tartrate-with-caffeine-a-futuristic-trend-of-intranasal-route
#14
JOURNAL ARTICLE
Preeti Dali, Pravin Shende
Objective: This research work aimed to form vesosomes using combination of two drugs ergotamine and caffeine for synergistic activity when given intranasally resulting in faster absorption, steric stability and controlled release. Significance: The multicompartment vesicles viz., vesosomes of ergotamine tartrate proved to increase absorption of drugs post-intranasal administration, bypassing the blood-brain barrier via the olfactory pathway Methods: The phospholipids like soya lecithin, cholesterol and dipalmitoyl phosphatidylcholine were used to form a multicompartment structure called vesosomes using ethanol-induced interdigitation of lipids as the preparation method...
December 30, 2023: Drug Development and Industrial Pharmacy
https://read.qxmd.com/read/38043968/history-of-migraine
#15
REVIEW
Peter J Koehler, Christopher J Boes
Migraine symptoms were described in ancient Babylonia, and supernatural forces were felt to play a role in etiology and treatment. This changed in the Greco-Roman period, when the (dis)balance of humors was considered in (patho)physiology and treatment based on this. Aretaeus distinguished between cephalalgia, cephalea, and heterocrania. The latter term was changed to hemicrania by Galen. Physicians in the 17th century attributed headache to the meninges, extracranial periost, and cranial blood vessels. As for the pathophysiology, Willis suggested intracranial vasoconstriction with subsequent dilatation...
2023: Handbook of Clinical Neurology
https://read.qxmd.com/read/38017020/investigating-subtypes-of-lung-adenocarcinoma-by-oxidative-stress-and-immunotherapy-related-genes
#16
JOURNAL ARTICLE
Guangliang Duan, Changxin Huang, Jiangang Zhao, Yinghong Zhang, Wenbin Zhao, Huiping Dai
Lung adenocarcinoma (LUAD) is one of the most widespread and fatal types of lung cancer. Oxidative stress, resulting from an imbalance in the production and accumulation of reactive oxygen species (ROS), is considered a promising therapeutic target for cancer treatment. Currently, immune checkpoint blockade (ICB) therapy is being explored as a potentially effective treatment for early-stage LUAD. In this research, we aim to identify distinct subtypes of LUAD patients by investigating genes associated with oxidative stress and immunotherapy...
November 27, 2023: Scientific Reports
https://read.qxmd.com/read/37760827/potentially-inappropriate-use-of-opioids-in-the-management-of-migraine-in-colombia
#17
JOURNAL ARTICLE
Manuel E Machado-Duque, Maria Fernanda Echeverry-Gutiérrez, Andrés Gaviria-Mendoza, Luis F Valladales-Restrepo, Jorge E Machado-Alba
RESEARCH OBJECTIVE: To identify the frequency of opioid use in a group of patients diagnosed with migraine in Colombia. METHODS: Study of a retrospective cohort of patients with a diagnosis of migraine and a first prescription of antimigraine drugs from emergency services and a priority outpatient clinic. Sociodemographic, clinical, and pharmacological variables were identified; a 12-month follow-up was carried out to identify the use of a new opioid. RESULTS: A total of 6309 patients with a diagnosis of migraine were identified, with a mean age of 35...
August 25, 2023: Biomedicines
https://read.qxmd.com/read/37556478/polypharmacology-guided-drug-repositioning-approach-for-sars-cov2
#18
JOURNAL ARTICLE
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, Kikrusenuo Kiewhuo, Selvaraman Nagamani, G Narahari Sastry
Drug repurposing has emerged as an important strategy and it has a great potential in identifying therapeutic applications for COVID-19. An extensive virtual screening of 4193 FDA approved drugs has been carried out against 24 proteins of SARS-CoV2 (NSP1-10 and NSP12-16, envelope, membrane, nucleoprotein, spike, ORF3a, ORF6, ORF7a, ORF8, and ORF9b). The drugs were classified into top 10 and bottom 10 drugs based on the docking scores followed by the distribution of their therapeutic indications. As a result, the top 10 drugs were found to have therapeutic indications for cancer, pain, neurological disorders, and viral and bacterial diseases...
2023: PloS One
https://read.qxmd.com/read/37490200/screening-of-potential-inhibitors-targeting-the-main-protease-structure-of-sars-cov-2-via-molecular-docking-and-approach-with-molecular-dynamics-rmsd-rmsf-h-bond-sasa-and-mmgbsa
#19
JOURNAL ARTICLE
Aluísio Marques da Fonseca, Bernardino Joaquim Caluaco, Junilson Martinho Canjanja Madureira, Sadrack Queque Cabongo, Eduardo Menezes Gaieta, Faustino Djata, Regilany Paulo Colares, Moises Maia Neto, Carla Freire Celedonio Fernandes, Gabrielle Silva Marinho, Hélcio Silva Dos Santos, Emmanuel Silva Marinho
Severe Acute Respiratory Syndrome caused by a coronavirus is a recent viral infection. There is no scientific evidence or clinical trials to indicate that possible therapies have demonstrated results in suspected or confirmed patients. This work aims to perform a virtual screening of 1430 ligands through molecular docking and to evaluate the possible inhibitory capacity of these drugs about the Mpro protease of Covid-19. The selected drugs were registered with the FDA and available in the virtual drug library, widely used by the population...
July 25, 2023: Molecular Biotechnology
https://read.qxmd.com/read/37460781/association-between-migraine-and-ischemic-cardio-cerebrovascular-disease-ccvd-and-effects-of-triptans-and-ergotamine-on-the-risk-of-ischemic-ccvd-in-patients-with-migraine-in-the-korean-nhis-heals-cohort
#20
JOURNAL ARTICLE
Yonghwan Kim, Sang-Jun Shin, Jae-Woo Lee, Ye-Seul Kim, Hyo-Sun You, Joungyoun Kim, Hee-Taik Kang
BACKGROUND AND OBJECTIVES: Triptans and ergotamine are commonly used to treat migraine, a risk factor for ischemic stroke. This study aimed to investigate the association between migraine and ischemic cardio-cerebrovascular disease (CCVD). Further analyses were performed to examine whether symptom-relieving treatment of migraine with triptans and ergotamine reduces ischemic CCVD in migraineurs. METHODS: Participants from the Korean NHIS-HEALS cohort database were divided into patients reporting headache without migraine (HA), migraineurs who received at least one prescription for triptans or ergotamine (TE), and migraineurs who were prescribed neither triptans nor ergotamine (NTNE)...
July 2023: Clinical Drug Investigation
keyword
keyword
51668
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.